My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1507

    1.

    Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

    Bektas N, Haaf A, Veeck J, Wild PJ, Lüscher-Firzlaff J, Hartmann A, Knüchel R, Dahl E.

    BMC Cancer. 2008 Feb 6;8:42.PMID: 18254960 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.

    Francis RE, Myatt SS, Krol J, Hartman J, Peck B, McGovern UB, Wang J, Guest SK, Filipovic A, Gojis O, Palmieri C, Peston D, Shousha S, Yu Q, Sicinski P, Coombes RC, Lam EW.

    Int J Oncol. 2009 Jul;35(1):57-68.PMID: 19513552 [PubMed - indexed for MEDLINE]Related articles

    3.

    Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

    ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

    BMC Cancer. 2009 Aug 25;9:298.PMID: 19706168 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

    Clin Cancer Res. 2005 Jun 15;11(12):4357-64.PMID: 15958618 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

    Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

    J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.PMID: 18037662 [PubMed - indexed for MEDLINE]Related articles

    6.

    Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.

    Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, Dürst M, Klinkhammer-Schalke M, Blaszyk H, Knuechel R, Hartmann A, Rosenthal A, Wild PJ.

    Clin Cancer Res. 2006 Jul 1;12(13):3950-60.PMID: 16818692 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.

    Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, Cheung AN, Ngan HY.

    J Pathol. 2008 Jul;215(3):245-52.PMID: 18464245 [PubMed - indexed for MEDLINE]Related articles

    8.

    Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.

    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.

    Clin Cancer Res. 2005 Dec 1;11(23):8348-57.PMID: 16322295 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.

    Cancer Res. 2002 Mar 15;62(6):1676-81.PMID: 11912139 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

    Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

    Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.PMID: 16244790 [PubMed - indexed for MEDLINE]Related articles

    11.

    A comparative assessment of HER2 status in operable breast cancer by real-time RT-PCR and by immunohistochemistry.

    Potemski P, Płuciennik E, Bednarek AK, Kusińska R, Pasz-Walczak G, Jesionek-Kupnicka D, Watala C, Kordek R.

    Med Sci Monit. 2006 Dec;12(12):MT57-61. Epub 2006 Nov 23.PMID: 17136015 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores.

    Schobesberger M, Baltzer A, Oberli A, Kappeler A, Gugger M, Burger H, Jaggi R.

    BMC Cancer. 2008 Nov 25;8:343.PMID: 19032762 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.

    Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knüchel R, Fasching PA, Dahl E.

    Breast Cancer Res. 2008;10(4):R58. Epub 2008 Jul 15.PMID: 18627608 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prostanoid receptor EP1 expression in breast cancer.

    Thorat MA, Morimiya A, Mehrotra S, Konger R, Badve SS.

    Mod Pathol. 2008 Jan;21(1):15-21. Epub 2007 Sep 28.PMID: 17906615 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".

    Menéndez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R.

    Clin Transl Oncol. 2006 Nov;8(11):812-20.PMID: 17134970 [PubMed - indexed for MEDLINE]Related articles

    16.

    Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.

    Mol Cancer. 2008 Nov 6;7:83.PMID: 18990230 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

    Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.PMID: 17671124 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.

    Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW.

    Mol Cancer Ther. 2008 Jul;7(7):2022-32.PMID: 18645012 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

    Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC.

    Clin Cancer Res. 2005 Aug 15;11(16):5869-77.PMID: 16115928 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.

    Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knüchel R, Dahl E.

    BMC Cancer. 2008 May 30;8:154.PMID: 18513385 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity